Related Experiment Video
Updated: Dec 10, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
Hypertension and Age-Related Cognitive Impairment: Common Risk Factors and a Role for Precision Aging
Meredith Hay1,2,3, Carol Barnes4,5, Matt Huentelman5,6
1Department of Physiology, University of Arizona, 1501 N Campbell Rd, Room 4103, Tucson, AZ, 85724, USA. mhay@arizona.edu.
Insights
Precision Aging® uses precision medicine to understand risks driving age-related cognitive impairment (ARCI). Shared mechanisms between hypertension and ARCI accelerate cognitive decline, necessitating personalized therapies for brain health.
Area of Science:
- Neuroscience
- Cardiovascular Science
- Gerontology
Background:
- Cognitive health span currently lags behind life span.
- Age-related cognitive impairment (ARCI) is a growing concern.
- Hypertension and cardiovascular disease are significant risk factors for ARCI.
Purpose of the Study:
- To explore the concept of Precision Aging® for understanding ARCI risk factors.
- To discuss common mechanisms linking hypertension and ARCI.
- To highlight the need for person-specific therapies to optimize brain health.
Main Methods:
- Review of existing literature on hypertension, cardiovascular disease, and ARCI.
- Analysis of shared underlying mechanisms between hypertension and ARCI.
- Discussion of the convergence of risk factors in individual patients.
Main Results:
- Hypertension and cardiovascular disease share numerous risk factors with ARCI.
- Common mechanisms can amplify individual risk, accelerating cognitive decline.
- Understanding these convergences is key to developing targeted interventions.
Conclusions:
- Precision Aging® offers a framework for personalized approaches to ARCI.
- Interventions must address shared risk factors and individual profiles.
- Optimizing brain health across the lifespan requires a comprehensive, individualized strategy.
Purpose Of Review:
Precision Aging® is a novel concept that we have recently employed to describe how the model of precision medicine can be used to understand and define the multivariate risks that drive age-related cognitive impairment (ARCI). Hypertension and cardiovascular disease are key risk factors for both brain function and cognitive aging. In this review, we will discuss the common mechanisms underlying the risk factors for both hypertension and ARCI and how the convergence of these mechanisms may be amplified in an individual to drive changes in brain health and accelerate cognitive decline.
Recent Findings:
Currently, our cognitive health span does not match our life span. Age-related cognitive impairment and preventing and treating ARCI will require an in-depth understanding of the interrelated risk factors, including individual genetic profiles, that affect brain health and brain aging. Hypertension and cardiovascular disease are important risk factors for ARCI. And, many of the risk factors for developing hypertension, such as diabetes, smoking, stress, viral infection, and age, are shared with the development of ARCI. We must first understand the mechanisms common to the converging risk factors in hypertension and ARCI and then design person-specific therapies to optimize individual brain health. The understanding of the convergence of shared risk factors between hypertension and ARCI is required to develop individualized interventions to optimize brain health across the life span. We will conclude with a discussion of possible steps that may be taken to decrease ARCI and optimize an individual's cognitive life span.
More Related Videos
Related Concept Videos
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Pharmacodynamics in Geriatric Patients: Effects of Age
Cognitive Development During Adulthood
Drug Dosing: Geriatric Patients
Hypertension and Regulation of Blood Pressure
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

